Forward therapeutics secures $50m to develop next-gen small molecule immune therapies
Longevity Technology - 09-Nov-2023Company's pipeline targets inflammation, promote healing, and restore quality of life
Join the club for FREE to access the whole archive and other member benefits.
Biotech firm accelerating discovery of next generation human medicines
Curie.Bio is a new model for venture capital in biotech focused on helping founders launch serious therapeutics companies. The company is a unique combination of two businesses: we act as both your drug discovery copilot & seed investor.
Curie.Bio does this by giving founders access to a team of the world’s best drug hunters and drug makers, seed capital, and best-of-breed services - everything a founder needs to get from concept to a compelling quality dataset that enables an awesome Series A financing.
Visit website: https://curie.bio/
Details last updated 14-Nov-2023
Company's pipeline targets inflammation, promote healing, and restore quality of life